Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension studyLuis Querol, Jérôme De Sèze, Tina Dysgaard, Todd Levine, T Hemanth Rao, Michael Rivner, Hans-Peter Hartung, Peter Kiessling, Saori Shimizu, Dominika Marmol, Ali Bozorg, Anny-Odile Colson, Ute Massow, Filip Eftimov, See the full list of authors
10 May 2024
Peripheral hearing loss at age 70 predicts brain atrophy and associated cognitive changeThomas D Parker, Chris Hardy, Sarah Keuss, William Coath, David M Cash, Kirsty Lu, Jennifer M Nicholas, Sarah-Naomi James, Carole Sudre, Sebastian Crutch, Doris-Eva Bamiou, Jason D Warren, Nick C Fox, Marcus Richards, Jonathan M Schott
3 April 2024
Patient-perceived progression in multiple system atrophy: natural history of quality of lifeTiphaine Saulnier, Margherita Fabbri, Mélanie Le Goff, Catherine Helmer, Anne Pavy-Le Traon, Wassilios G. Meissner, Olivier Rascol, Cecile Proust-Lima, Alexandra Foubert-Samier
7 March 2024
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI studyChristoph Linnemann, Carlo Wilke, David Mengel, Henrik Zetterberg, Carolin Heller, Jens Kuhle, Arabella Bouzigues, Lucy L Russell, Phoebe H Foster, Eve Ferry-Bolder, John Cornelis Van Swieten, Lize C Jiskoot, Harro Seelaar, Fermin Moreno, Barbara BorroniSee the full list of authors
19 January 2024
Implications for driving based on the risk of seizures after ischaemic strokeKai Michael Schubert, Giulio Bicciato, Lucia Sinka, Laura Abraira, Estevo Santamarina, José Álvarez-Sabín, Carolina Ferreira-Atuesta, Mira Katan, Natalie Scherrer, Robert Terziev, Nico Döhler, Barbara Erdélyi-Canavese, Ansgar Felbecker, Philip Siebel, Michael WinklehnerSee the full list of authors
15 May 2024
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s diseaseRuth Dobson, Katherine Patterson, Reshad Malik, Uttara Mandal, Hina Asif, Ros Humphreys, Michael Payne, Eng O-Charoenrat, Lauren Huzzey, Adam Clare, Kate Green, Maija Morton, Catrin Sohrabi, Navreen Singh, Amirtha PasupathySee the full list of authors
11 June 2024
Predicting how many people might receive treatment with new therapies for Alzheimer’s diseaseBenjamin R Underwood
11 June 2024
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccinationNiels J M Verstegen, Ruth R Hagen, Christine Kreher, Lisan H Kuijper, Jet van den Dijssel, Thomas Ashhurst, Laura Y L Kummer, Virginia Palomares Cabeza, Maurice Steenhuis, Mariël C Duurland, Rivka de Jongh, C Ellen van der Schoot, Veronique A L Konijn, Erik Mul, Katherine KedzierskaSee the full list of authors
28 March 2024
Pain and functional neurological disorder: a systematic review and meta-analysisMoritz Steinruecke, Isabel Mason, Mairi Keen, Laura McWhirter, Alan J Carson, Jon Stone, Ingrid Hoeritzauer
21 February 2024
Cortical inexcitability in ALS: correlating a clinical phenotypeNathan Pavey, Andrew Hannaford, Mana Higashihara, Mehdi van den Bos, Nimeshan Geevasinga, Steve Vucic, Parvathi Menon
13 August 2024
